Sandro Pignata

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 48

Top Topics

Venous Thromboembolism

Newly Diagnosed

Top Venues

British journal of cancer

Journal of gynecologic oncology

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Miriam Dellino, Francescapaola Magazzino, Lavinia Domenici, Stefania Cicogna, Salvatora Tindara Miano, Sandro Pignata, Giorgia Mangili, Gennaro Cormio
Aggressive Angiomyxoma of the Lower Female Genital Tract: A Review of the MITO Rare Tumors Group. Cancers 16 (7) (2024)
Innocenza Palaia, Giuseppe Caruso, Violante Di Donato, Camilla Turetta, Antonella Savarese, Giorgia Perniola, Roberta Gallo, Andrea Giannini, Vanda Salutari, Giorgio Bogani, Federica Tomao, Diana Giannarelli, Gabriella Gentile, Angela Musella, Ludovico Muzii, Sandro Pignata, null null
Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey. Journal of gynecologic oncology 35 (3) (2024)
Francescapaola Magazzino, Cynthia Aristei, Anna Passarelli, Antonio Pierini, Ugo De Giorgi, Ruby Martinello, Lavinia Domenici, Sandro Pignata, Giorgia Mangili, Gennaro Cormio
Lymphomas of the Vulva: A Review of the MITO Rare Cancer Group. Cancers 16 (11) (2024)
Innocenza Palaia, Giuseppe Caruso, Violante Di Donato, Camilla Turetta, Antonella Savarese, Giorgia Perniola, Roberta Gallo, Andrea Giannini, Vanda Salutari, Giorgio Bogani, Federica Tomao, Diana Giannarelli, Gabriella Gentile, Angela Musella, Ludovico Muzii, Sandro Pignata, null null
Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey. Journal of gynecologic oncology 35 (3) (2024)
Sara Santagata, Giuseppina Rea, Anna Maria Bello, Anna Capiluongo, Maria Napolitano, Sonia Desicato, Alessandra Fragale, Crescenzo D'Alterio, Anna Maria Trotta, Caterina Ieranò, Luigi Portella, Francesco Persico, Marilena Di Napoli, Salvatore Di Maro, Florinda Feroce, Rosa Azzaro, Lucia Gabriele, Nicola Longo, Sandro Pignata, Sisto Perdonà, Stefania Scala
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients. British journal of cancer 130 (12) (2024)
Rosanna Mancari, Raffaella Cioffi, Francescapaola Magazzino, Laura Attademo, Miriam Sant'Angelo, Gianluca Taccagni, Giorgia Mangili, Sandro Pignata, Alice Bergamini
Dermatofibrosarcoma Protuberans of the Vulva: A Review of the MITO Rare Cancer Group. Cancers 16 (1) (2024)
Miriam Dellino, Francescapaola Magazzino, Lavinia Domenici, Stefania Cicogna, Salvatora Tindara Miano, Sandro Pignata, Giorgia Mangili, Gennaro Cormio
Aggressive Angiomyxoma of the Lower Female Genital Tract: A Review of the MITO Rare Tumors Group. Cancers 16 (7) (2024)
Innocenza Palaia, Giuseppe Caruso, Violante Di Donato, Camilla Turetta, Antonella Savarese, Giorgia Perniola, Roberta Gallo, Andrea Giannini, Vanda Salutari, Giorgio Bogani, Federica Tomao, Diana Giannarelli, Gabriella Gentile, Angela Musella, Ludovico Muzii, Sandro Pignata, null null
Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey. Journal of gynecologic oncology (2024)
Sara Santagata, Giuseppina Rea, Anna Maria Bello, Anna Capiluongo, Maria Napolitano, Sonia Desicato, Alessandra Fragale, Crescenzo D'Alterio, Anna Maria Trotta, Caterina Ieranò, Luigi Portella, Francesco Persico, Marilena Di Napoli, Salvatore Di Maro, Florinda Feroce, Rosa Azzaro, Lucia Gabriele, Nicola Longo, Sandro Pignata, Sisto Perdonà, Stefania Scala
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients. British journal of cancer (2024)
Sara Santagata, Anna Maria Trotta, Crescenzo D'Alterio, Maria Napolitano, Giuseppina Rea, Marilena Di Napoli, Luigi Portella, Caterina Ieranò, Giuseppe Guardascione, Elisabetta Coppola, Christophe Caux, Bertrand Dubois, Helen J Boyle, Joan Carles, Sabrina Rossetti, Rosa Azzaro, Florinda Feroce, Sisto Perdonà, Mario Fordellone, Anna Maria Bello, Daniela Califano, Paolo Chiodini, Sandro Pignata, Stefania Scala
KIR2DL2/DL3+NKs and Helios+Tregs in peripheral blood predict nivolumab response in patients with metastatic renal cell cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Francescapaola Magazzino, Cynthia Aristei, Anna Passarelli, Antonio Pierini, Ugo De Giorgi, Ruby Martinello, Lavinia Domenici, Sandro Pignata, Giorgia Mangili, Gennaro Cormio
Lymphomas of the Vulva: A Review of the MITO Rare Cancer Group. Cancers 16 (11) (2024)
Innocenza Palaia, Giuseppe Caruso, Violante Di Donato, Camilla Turetta, Antonella Savarese, Giorgia Perniola, Roberta Gallo, Andrea Giannini, Vanda Salutari, Giorgio Bogani, Federica Tomao, Diana Giannarelli, Gabriella Gentile, Angela Musella, Ludovico Muzii, Sandro Pignata, null null
Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey. Journal of gynecologic oncology 35 (3) (2024)
Sara Santagata, Giuseppina Rea, Anna Maria Bello, Anna Capiluongo, Maria Napolitano, Sonia Desicato, Alessandra Fragale, Crescenzo D'Alterio, Anna Maria Trotta, Caterina Ieranò, Luigi Portella, Francesco Persico, Marilena Di Napoli, Salvatore Di Maro, Florinda Feroce, Rosa Azzaro, Lucia Gabriele, Nicola Longo, Sandro Pignata, Sisto Perdonà, Stefania Scala
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients. British journal of cancer 130 (12) (2024)
Miriam Dellino, Francescapaola Magazzino, Lavinia Domenici, Stefania Cicogna, Salvatora Tindara Miano, Sandro Pignata, Giorgia Mangili, Gennaro Cormio
Aggressive Angiomyxoma of the Lower Female Genital Tract: A Review of the MITO Rare Tumors Group. Cancers 16 (7) (2024)
Rosanna Mancari, Raffaella Cioffi, Francescapaola Magazzino, Laura Attademo, Miriam Sant'Angelo, Gianluca Taccagni, Giorgia Mangili, Sandro Pignata, Alice Bergamini
Dermatofibrosarcoma Protuberans of the Vulva: A Review of the MITO Rare Cancer Group. Cancers 16 (1) (2024)
Sara Santagata, Giuseppina Rea, Anna Maria Bello, Anna Capiluongo, Maria Napolitano, Sonia Desicato, Alessandra Fragale, Crescenzo D'Alterio, Anna Maria Trotta, Caterina Ieranò, Luigi Portella, Francesco Persico, Marilena Di Napoli, Salvatore Di Maro, Florinda Feroce, Rosa Azzaro, Lucia Gabriele, Nicola Longo, Sandro Pignata, Sisto Perdonà, Stefania Scala
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients. British journal of cancer 130 (12) (2024)
Sara Santagata, Giuseppina Rea, Anna Maria Bello, Anna Capiluongo, Maria Napolitano, Sonia Desicato, Alessandra Fragale, Crescenzo D'Alterio, Anna Maria Trotta, Caterina Ieranò, Luigi Portella, Francesco Persico, Marilena Di Napoli, Salvatore Di Maro, Florinda Feroce, Rosa Azzaro, Lucia Gabriele, Nicola Longo, Sandro Pignata, Sisto Perdonà, Stefania Scala
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients. British journal of cancer 130 (12) (2024)
Michele Mongelli, Domenica Lorusso, Vanna Zanagnolo, Sandro Pignata, Nicoletta Colombo, Gennaro Cormio
Venous Thromboembolism Prophylaxis in Gynecologic Oncology: A MITO-MaNGO Survey. Diagnostics (Basel, Switzerland) 14 (11) (2024)
Michele Mongelli, Domenica Lorusso, Vanna Zanagnolo, Sandro Pignata, Nicoletta Colombo, Gennaro Cormio
Venous Thromboembolism Prophylaxis in Gynecologic Oncology: A MITO-MaNGO Survey. Diagnostics (Basel, Switzerland) 14 (11) (2024)
Valentina Tuninetti, Eleonora Ghisoni, Sandro Pignata, Elisa Picardo, Francesco Raspagliesi, Claudia Andreetta, Elena Maldi, Grazia Artioli, Serafina Mammoliti, Lucia Zanchi, Angelica Sikokis, Nicoletta Biglia, Maria Concetta Fargnoli, Vincenzo Dario Mandato, Claudia Carella, Gennaro Cormio, Marco Marinaccio, Andrea Puppo, Biagio Paolini, Lucia Borsotti, Giulia Scotto, Margherita Turinetto, Dario Sangiolo, Massimo Di Maio, Giorgio Valabrega
Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study. Cancers 15 (4) (2023)
Charles N Landen, Luciana L Molinero, Habib Hamidi, Jalid Sehouli, Austin Miller, Kathleen M Moore, Cagatay Taskıran, Michael A Bookman, Kristina Lindemann, Charles Anderson, Regina Berger, Tashanna Myers, Mario Beiner, Thomas Reid, Els Van Nieuwenhuysen, Andrew Green, Aikou Okamoto, Carol Aghajanian, Premal H Thaker, Stephanie V Blank, Victor K Khor, Ching-Wei Chang, Yvonne G Lin, Sandro Pignata
Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Rachel N Grisham, Ignace Vergote, Susana Banerjee, Esther Drill, Elsa Kalbacher, Mansoor Raza Mirza, Ignacio Romero, Peter Vuylsteke, Robert L Coleman, Felix Hilpert, Amit M Oza, Anneke M Westermann, Martin K Oehler, Sandro Pignata, Carol Aghajanian, Nicoletta Colombo, David Cibula, Kathleen M Moore, Josep M Del Campo, Regina Berger, Christian Marth, Jalid Sehouli, David M O'Malley, Cristina Churruca, Gunnar B Kristensen, Andrew R Clamp, John Farley, Gopakumar V Iyer, Isabelle L Ray-Coquard, Bradley J Monk
Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Eric Pujade-Lauraine, Jessica Brown, Alan Barnicle, Jonathan Wessen, Pierre Lao-Sirieix, Steven W Criscione, Andreas du Bois, Domenica Lorusso, Ignacio Romero, Edgar Petru, Hiroyuki Yoshida, Ignace Vergote, Nicoletta Colombo, Sakari Hietanen, Magali Provansal, Barbara Schmalfeldt, Sandro Pignata, Cristina Martín Lorente, Dominique Berton-Rigaud, Ingo B Runnebaum, Isabelle L Ray-Coquard
Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial. JCO precision oncology 7 (2023)
Margherita Turinetto, Andrea Ricotti, Claudia Marchetti, Carmela Pisano, Claudio Zamagni, Chiara Cassani, Paola Malaguti, Alessandra Baldoni, Paolo Scollo, Giuseppa Scandurra, Alessandro Parisi, Grazia Artioli, Innocenza Palaia, Laura Vertechy, Alice Bergamini, Elisa Picardo, Valentina Tuninetti, Giulia Scotto, Giovanni Scambia, Sandro Pignata, Giorgio Valabrega
MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)-Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors-A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study. Cancers 16 (1) (2023)
Eric Pujade-Lauraine, Jessica Brown, Alan Barnicle, Jonathan Wessen, Pierre Lao-Sirieix, Steven W Criscione, Andreas du Bois, Domenica Lorusso, Ignacio Romero, Edgar Petru, Hiroyuki Yoshida, Ignace Vergote, Nicoletta Colombo, Sakari Hietanen, Magali Provansal, Barbara Schmalfeldt, Sandro Pignata, Cristina Martín Lorente, Dominique Berton-Rigaud, Ingo B Runnebaum, Isabelle L Ray-Coquard
Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial. JCO precision oncology 7 (2023)
Ursula A Matulonis, Domenica Lorusso, Ana Oaknin, Sandro Pignata, Andrew Dean, Hannelore G Denys, Nicoletta Colombo, Toon Van Gorp, Jason A Konner, Margarita Romeo Marin, Philipp Harter, Conleth G Murphy, Jiuzhou Wang, Elizabeth Noble, Brooke Esteves, Michael Method, Robert L Coleman
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Giuseppe Caruso, Amelia Barcellini, Roberta Mazzeo, Roberta Gallo, Maria Giuseppa Vitale, Anna Passarelli, Giorgia Mangili, Sandro Pignata, Innocenza Palaia
Vulvar Paget's Disease: A Systematic Review of the MITO Rare Cancer Group. Cancers 15 (6) (2023)
Eric Pujade-Lauraine, Jessica Brown, Alan Barnicle, Jonathan Wessen, Pierre Lao-Sirieix, Steven W Criscione, Andreas du Bois, Domenica Lorusso, Ignacio Romero, Edgar Petru, Hiroyuki Yoshida, Ignace Vergote, Nicoletta Colombo, Sakari Hietanen, Magali Provansal, Barbara Schmalfeldt, Sandro Pignata, Cristina Martín Lorente, Dominique Berton-Rigaud, Ingo B Runnebaum, Isabelle L Ray-Coquard
Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial. JCO precision oncology 7 (2023)
Amelia Barcellini, Andrei Fodor, Alexandra Charalampopoulou, Chiara Cassani, Laura Deborah Locati, Raffaella Cioffi, Alice Bergamini, Sandro Pignata, Ester Orlandi, Giorgia Mangili
Radiation Therapy for Gestational Trophoblastic Neoplasia: Forward-Looking Lessons Learnt. Cancers 15 (19) (2023)
Giuseppe Caruso, Amelia Barcellini, Roberta Mazzeo, Roberta Gallo, Maria Giuseppa Vitale, Anna Passarelli, Giorgia Mangili, Sandro Pignata, Innocenza Palaia
Vulvar Paget's Disease: A Systematic Review of the MITO Rare Cancer Group. Cancers 15 (6) (2023)
Stefania Cicogna, Miriam Dellino, Salvatora Tindara Miano, Francescapaola Magazzino, Lavinia Domenici, Sandro Pignata, Giorgia Mangili, Gennaro Cormio
Aggressive Angiomyxoma of the Lower Female Genital Tract in Pregnancy: A Review of the MITO Rare Tumors Group. Cancers 15 (13) (2023)
Valentina Tuninetti, Eleonora Ghisoni, Sandro Pignata, Elisa Picardo, Francesco Raspagliesi, Claudia Andreetta, Elena Maldi, Grazia Artioli, Serafina Mammoliti, Lucia Zanchi, Angelica Sikokis, Nicoletta Biglia, Maria Concetta Fargnoli, Vincenzo Dario Mandato, Claudia Carella, Gennaro Cormio, Marco Marinaccio, Andrea Puppo, Biagio Paolini, Lucia Borsotti, Giulia Scotto, Margherita Turinetto, Dario Sangiolo, Massimo Di Maio, Giorgio Valabrega
Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study. Cancers 15 (4) (2023)
Giovanni Luca Scaglione, Sandro Pignata, Angela Pettinato, Carmela Paolillo, Daniela Califano, Giuseppa Scandurra, Valentina Lombardo, Francesca Di Gaudio, Basilio Pecorino, Liliana Mereu, Paolo Scollo, Ettore D Capoluongo
Homologous Recombination Deficiency (HRD) Scoring, by Means of Two Different Shallow Whole-Genome Sequencing Pipelines (sWGS), in Ovarian Cancer Patients: A Comparison with Myriad MyChoice Assay. International journal of molecular sciences 24 (23) (2023)
Ursula A Matulonis, Domenica Lorusso, Ana Oaknin, Sandro Pignata, Andrew Dean, Hannelore G Denys, Nicoletta Colombo, Toon Van Gorp, Jason A Konner, Margarita Romeo Marin, Philipp Harter, Conleth G Murphy, Jiuzhou Wang, Elizabeth Noble, Brooke Esteves, Michael Method, Robert L Coleman
Reply to Z.R. McCaw et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Margherita Turinetto, Andrea Ricotti, Claudia Marchetti, Carmela Pisano, Claudio Zamagni, Chiara Cassani, Paola Malaguti, Alessandra Baldoni, Paolo Scollo, Giuseppa Scandurra, Alessandro Parisi, Grazia Artioli, Innocenza Palaia, Laura Vertechy, Alice Bergamini, Elisa Picardo, Valentina Tuninetti, Giulia Scotto, Giovanni Scambia, Sandro Pignata, Giorgio Valabrega
MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)-Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors-A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study. Cancers 16 (1) (2023)
Stefano Greggi, Francesca Falcone, Giovanni D Aletti, Marco Cascella, Francesca Bifulco, Nicoletta Colombo, Sandro Pignata
Evaluation of perioperative management of advanced ovarian (tubal/peritoneal) cancer patients: a survey from MITO-MaNGO Groups. Journal of gynecologic oncology 33 (5) (2022)
Amelia Barcellini, Alexandra Charalampopoulou, Loris De Cecco, Andrei Fodor, Emanuela Rabaiotti, Giorgio Candotti, Simona Secondino, Angelica Facoetti, Laura Deborah Locati, Sandro Pignata, Ester Orlandi, Giorgia Mangili
Ovarian Cancer Radiosensitivity: What Have We Understood So Far? Life (Basel, Switzerland) 13 (1) (2022)
Rossella Di Franco, Valentina Borzillo, Esmeralda Scipilliti, Gianluca Ametrano, Marcello Serra, Cecilia Arrichiello, Federica Savino, Fortuna De Martino, Valentina D'Alesio, Fabrizio Cammarota, Anna Crispo, Sandro Pignata, Sabrina Rossetti, Giuseppe Quarto, Paolo Muto
Reirradiation of Locally Recurrent Prostate Cancer with Cyberknife ® System or Volumetric Modulated Arc Therapy (VMAT) and IGRT-Clarity ® : Outcomes, Toxicities and Dosimetric Evaluation. Cancers 14 (13) (2022)
Martina Amato, Renato Franco, Gaetano Facchini, Raffaele Addeo, Fortunato Ciardiello, Massimiliano Berretta, Giulia Vita, Alessandro Sgambato, Sandro Pignata, Michele Caraglia, Marina Accardo, Federica Zito Marino
Microsatellite Instability: From the Implementation of the Detection to a Prognostic and Predictive Role in Cancers. International journal of molecular sciences 23 (15) (2022)
Amelia Barcellini, Alexandra Charalampopoulou, Loris De Cecco, Andrei Fodor, Emanuela Rabaiotti, Giorgio Candotti, Simona Secondino, Angelica Facoetti, Laura Deborah Locati, Sandro Pignata, Ester Orlandi, Giorgia Mangili
Ovarian Cancer Radiosensitivity: What Have We Understood So Far? Life (Basel, Switzerland) 13 (1) (2022)
Amelia Barcellini, Alexandra Charalampopoulou, Loris De Cecco, Andrei Fodor, Emanuela Rabaiotti, Giorgio Candotti, Simona Secondino, Angelica Facoetti, Laura Deborah Locati, Sandro Pignata, Ester Orlandi, Giorgia Mangili
Ovarian Cancer Radiosensitivity: What Have We Understood So Far? Life (Basel, Switzerland) 13 (1) (2022)
Lucia Musacchio, Daniela Califano, Michele Bartoletti, Laura Arenare, Domenica Lorusso, Nunzia Simona Losito, Gennaro Cormio, Stefano Greggi, Francesco Raspagliesi, Giorgio Valabrega, Vanda Salutari, Carmela Pisano, Anna Spina, Daniela Russo, Michele Del Sesto, Vincenzo Canzonieri, Francesco Ferraù, Gian Franco Zannoni, Vera Loizzi, Viola Ghizzoni, Claudia Casanova, Valentina Tuninetti, Monika Ducceschi, Vittoria Del Vecchio, Simona Scalone, Domenico Priolo, Francesco Perrone, Giovanni Scambia, Sandro Pignata
Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22). British journal of cancer 127 (8) (2022)
Miriam Dellino, Stefania Cicogna, Francesca Falcone, Marco Mitidieri, Roberta Mazzeo, Sandro Pignata, Giorgia Mangili, Gennaro Cormio
"Intestinal-Type" Vulvar Adenocarcinoma: A Review of the MITO Rare Tumors Group. Cancers 14 (20) (2022)
Marina Fabbi, Delfina Costa, Daniela Russo, Laura Arenare, Gabriele Gaggero, Simona Signoriello, Giovanni Scambia, Carmela Pisano, Nicoletta Colombo, Nunzia Simona Losito, Gilberto Filaci, Anna Spina, Daniela Califano, Giosuè Scognamiglio, Angiolo Gadducci, Mezzanzanica Delia, Marina Bagnoli, Silvano Ferrini, Vincenzo Canzonieri, Paolo Chiodini, Francesco Perrone, Sandro Pignata
Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab. Diagnostics (Basel, Switzerland) 12 (9) (2022)
Melissa Bersanelli, Giulia Mazzaschi, Patrizia Giannatempo, Daniele Raggi, Elena Farè, Maruzzo Marco, Umberto Basso, Ugo De Giorgi, Francesca Vignani, Giuseppe Luigi Banna, Marco Stellato, Rosa Tambaro, Emanuele Naglieri, Tania Losanno, Giuseppe Procopio, Sandro Pignata, Andrea Necchi, Sebastiano Buti
Immunotherapy and Sonpavde score validation in advanced upper tract urothelial carcinoma: a retrospective study by the Italian Network for Research in Urologic-Oncology. Immunotherapy (2021)
Kathleen M Moore, Michael A Bookman, Jalid Sehouli, Austin Miller, Charles Anderson, Giovanni Scambia, Tashanna Myers, Cagatay Taskiran, Katina Robison, Johanna Maenpaa, Lyndsay Willmott, Nicoletta Colombo, Jessica Thomes-Pepin, Michalis Liontos, Michael A Gold, Yolanda Garcia, Sudarshan K Sharma, Christopher J Darus, Carol Aghajanian, Aikou Okamoto, Xiaohua Wu, Rustem Safin, Fan Wu, Luciana L Molinero, Vidya Maiya, Victor K Khor, Yvonne G Lin, Sandro Pignata
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (17) (2021)
Sandro Pignata, Giovanni Scambia, Alessandro Villanucci, Emanuele Naglieri, Mikel Arruti Ibarbia, Federica Brusa, Hugues Bourgeois, Roberto Sorio, Antonio Casado, Dietmar Reichert, Catherine Dopchie, Beatriz De Rivas, Luis Miguel de Sande
A European, Observational, Prospective Trial of Trabectedin Plus Pegylated Liposomal Doxorubicin in Patients with Platinum-Sensitive Ovarian Cancer. The oncologist 26 (4) (2021)
Giorgio Bogani, Giovanni Apolone, Antonino Ditto, Giovanni Scambia, Pierluigi Benedetti Panici, Roberto Angioli, Sandro Pignata, Stefano Greggi, Paolo Scollo, Mezzanzanica Delia, Massimo Franchi, Fabio Martinelli, Mauro Signorelli, Salvatore Lopez, Violante Di Donato, Giorgio Valabrega, Gabriella Ferrandina, Innocenza Palaia, Alice Bergamini, Luca Bocciolone, Antonella Savarese, Fabio Ghezzi, Jvan Casarin, Ciro Pinelli, Vito Trojano, Vito Chiantera, Giorgio Giorda, Francesco Sopracordevole, Mario Malzoni, Giovanna Salerno, Enrico Sartori, Antonia Carla Testa, Gianfranco Zannoni, Fulvio Zullo, Enrico Vizza, Giuseppe Trojano, Antonio Chiantera, Francesco Raspagliesi
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups. Journal of gynecologic oncology 31 (6) (2020)